Results 1 to 10 of about 32,095 (195)

Extra-musculoskeletal manifestations driving the therapeutic decision-making in patients with Spondyloarthritis: a 12-month follow-up prospective cohort study

open access: yesAdvances in Rheumatology, 2023
Background The extra-musculoskeletal manifestations (EMMs) such as recurrent acute anterior uveitis (rAAU), psoriasis (Ps), and inflammatory bowel disease (IBD), are related to the Spondyloarthritis (SpA), as well as they are associated with disease ...
Danielle dos Reis Annunciato   +3 more
doaj   +1 more source

Association of Genetic Marker HLA-B27 with Spondyloarthritis In A Tertiary Care Centre In South India

open access: yesJournal of Pure and Applied Microbiology, 2022
Human leukocyte antigens (HLA) are gene products found in the major histocompatibility complex, aiding in differentiation of “self” from “non-self” antigens, and is crucial for the communication between immune cells of the human body.
T. Jayaprakash   +5 more
doaj   +1 more source

Differentiating nonradiographic axial spondyloarthritis from its mimics: a narrative review

open access: yesBMC Musculoskeletal Disorders, 2022
Background Optimal treatment of nonradiographic axial spondyloarthritis depends on accurate and timely diagnosis of the underlying disease; however, patients present with common symptoms that, in the absence of radiographic changes, may confound ...
Philip Mease, Atul Deodhar
doaj   +1 more source

Axial and peripheral spondyloarthritis triggered by sars-cov-2 infection: a report of two cases

open access: yesReumatismo, 2021
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection can show musculoskeletal symptoms such as peripheral arthritis. In rare cases, peripheral arthritis can develop after the resolution of SARS-CoV-2.
G. El Hasbani, A. Jawad, I. Uthman
doaj   +1 more source

Causal relationship between spondylarthritis and stroke in a European population: a two sample Mendelian randomization study

open access: yesFrontiers in Immunology, 2023
BackgroundObservational studies have found an increased risk of stroke in patients with spondyloarthritis, but the results are susceptible to reverse causality and confounders.
Luofei Zhang   +7 more
doaj   +1 more source

The Interleukine-17 Cytokine Family: Role in Development and Progression of Spondyloarthritis, Current and Potential Therapeutic Inhibitors

open access: yesBiomedicines, 2023
Spondyloarthritis (SpA) encompasses a group of chronic inflammatory rheumatic diseases with a predilection for the spinal and sacroiliac joints, which include axial spondyloarthritis, psoriatic arthritis, reactive arthritis, arthritis associated with ...
Anna Davydova   +4 more
doaj   +1 more source

Interleukin-17–targeted treatment in patients with spondyloarthritis and associated cardiometabolic risk profile

open access: yesFrontiers in Immunology, 2023
Spondyloarthritis is a group of immune-mediated rheumatic disorders that significantly impact patients’ physical function and quality of life. Patients with spondyloarthritis experience a greater prevalence of cardiometabolic disorders, such as obesity ...
Rubén Queiro   +8 more
doaj   +1 more source

Axial Spondyloarthritis after bariatric surgery: a 7-year retrospective analysis

open access: yesAdvances in Rheumatology, 2019
Background In recent decades, obesity has become a public health problem in many countries. The objective of this study was to evaluate the main joint and extra-articular manifestations related to spondyloarthritis (SpA) after bariatric surgery (BS) in a
Thauana Luiza de Oliveira   +2 more
doaj   +1 more source

Understanding the Pathogenesis of Spondyloarthritis

open access: yesBiomolecules, 2020
Spondyloarthritis comprises a group of inflammatory diseases of the joints and spine, with various clinical manifestations. The group includes ankylosing spondylitis, reactive arthritis, psoriatic arthritis, arthritis associated with inflammatory bowel ...
Aigul Sharip, Jeannette Kunz
doaj   +1 more source

Persistence of biological agents over an eight-year period in rheumatoid arthritis and spondyloarthritis patients [PDF]

open access: yesFarmacia Hospitalaria, 2019
Objective: To calculate the persistence, over a period of eight years, the retention rate of first and second-line of treatment with biological agents in patients with rheumatoid arthritis, spondyloarthritis and psoriatic arthritis and to compare ...
María Ángeles González-Fernández   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy